Cannell & Spears LLC

Position in AXSM — Axsome Therapeutics, Inc.

CIK 1426319 NEW YORK, NY

Position in AXSM

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$20,598,374

+$6,374,665 QoQ

Shares Held

84,154

0.0% QoQ

Ownership

0.161%

of shares outstanding

% of Portfolio

0.38%

of 13F equity value

Holder Rank

#81

of 500 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Cannell & Spears LLC holds $44,689,983 across 5 Biotechnology names. AXSM ranks #2 (46.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	36,099	$22,509,170
2	AXSM	Axsome Therapeutics, Inc. This page	84,154	$20,598,374
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,966	$976,571
4	FTRE	Fortrea Holdings Inc.	31,315	$544,881
5	ALEC	Alector, Inc.	30,342	$60,987

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$20,598,374	84,154	0.0%	Shares	Sole	2026-08-11
2026-03-31	$14,223,709	84,154	0.0%	Shares	Sole	2026-05-15
2025-12-31	$15,369,886	84,154	+0.0%	Shares	Sole	2026-02-17
2025-09-30	$10,220,138	84,151	0.0%	Shares	Sole	2025-11-14
2025-06-30	$8,784,522	84,151	-0.1%	Shares	Sole	2025-08-14
2025-03-31	$9,827,710	84,264	+2.7%	Shares	Sole	2025-05-14
2024-12-31	$6,945,381	82,087	0.0%	Shares	Sole	2025-02-12
2024-09-30	$7,377,158	82,087	-0.0%	Shares	Sole	2024-11-12
2024-06-30	$6,608,406	82,092	-0.8%	Shares	Sole	2024-08-12
2024-03-31	$6,601,854	82,730	—	Shares	Sole	2024-05-10
No filing history on record for this holder in this stock.